PVLA Palvella Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 4, 2026
$132,47
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$65,93minimo 52 sett.
$161,38massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$1.91B
P/E
-35.7
EPS
$-3.71
Ricavi
$43M
i tuoi badge
Intervallo 52 sett.
$66–$161
Rating Analisti
BUY
Prezzo Obiettivo
$231
P/E
-35.7
ROE
-110.1%
Margine di Profitto Netto
-1610.6%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
PVLA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$132.47
Capitalizzazione di Mercato (MRQ)
$1.91B
P/E
-35.7
EPS
$-3.71
Ricavi
$43M
ROE
-110.1%
Intervallo 52 sett.
$66–$161
PVLA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 23 Aprile 2024 | 1-for-80 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$43M2017-12-31 → 2023-12-31
EPS$-3.712020-12-31 → 2025-12-31
Flusso di cassa libero·2017-12-31 → 2022-12-31
Margine netto-1610.6%2017-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | PVLA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -35.7media 5 anni ≈-113.6 | ≈-113.6 | · | · | |
| P/S | 83.8media 5 anni ≈104.1 | ≈104.1 | 25.9 | Sopravvalutato | |
| P/B (MRQ) | 8.8media 5 anni ≈90.1 | ≈90.1 | 5.4 | Sopravvalutato | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -65.6media 5 anni ≈-55.8 | ≈-55.8 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 58.6media 5 anni ≈159.6 | ≈159.6 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | PVLA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Operating Margin (Margine Operativo) | -1490.4% | · | -668.2% | Sotto la media | |
| EBITDA Margin (Margine EBITDA) | -1490.4% | · | -668.2% | Sotto la media | |
| Pretax Margin (Margine ante imposte) | -1610.6% | · | -765.9% | Debole | |
| Net Profit Margin (Margine di Profitto Netto) | -1610.6% | · | -669.0% | Sotto la media | |
| ROA | -56.5%media 5 anni ≈-39.9% | ≈-39.9% | -42.9% | Debole | |
| ROE | -110.1%media 5 anni ≈-20.5% | ≈-20.5% | -60.0% | Debole | |
| ROIC | -137.9%media 5 anni ≈-105.4% | ≈-105.4% | -62.3% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | PVLA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 21.2media 5 anni ≈4.8 | ≈4.8 | 6.0 | Liquidità elevata | |
| Quick Ratio | 5.1media 5 anni ≈4.6 | ≈4.6 | 4.4 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | PVLA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 65.3%media 5 anni ≈18.3% | ≈18.3% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 13.4% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | PVLA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0 | · | 0.1 | Debole | |
| Receivables Turnover (Rotazione dei crediti) | 14.5 | · | 4.6 | Di prim'ordine | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$1.5M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-53.9%
Prossimo report
Nov 09, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 13, 2026 | $-1.52 | $-1.18 | -28.5% |
| 31 Marzo 2026 | Mag 14, 2026 | $-1.20 | $-0.95 | -26.2% |
| 31 Dicembre 2025 | $-1.07 | $-0.93 | -15.2% | |
| 30 Settembre 2025 | $-1.03 | $-0.86 | -20.5% | |
| 30 Giugno 2025 | $-0.86 | $-0.76 | -13.8% | |
| 31 Marzo 2025 | $-0.74 | $-1.24 | 40.1% | |
| 31 Dicembre 2024 | $-2.72 | $-0.66 | -313.4% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| R&D Expense | $23M | $8M | $9M | $53M | $67M | $47M | $55M | $41M | $22M | $20M | $8M | $6M | |
| SG&A Expense | $16M | $6M | $3M | $16M | $17M | $17M | $18M | $18M | $18M | $9M | $8M | $7M | |
| Operating Expenses | $39M | $14M | $12M | $69M | $83M | $63M | $73M | $60M | $40M | $29M | $17M | $13M | |
| Operating Income | $-39M | $-14M | $-12M | $-43M | $-52M | $-34M | $-27M | $-31M | $-15M | $-23M | $-14M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Other Non-op | $727.0K | $-131.0K | $712.0K | $1M | $2M | $-4M | $-26.0K | $2M | $-2M | $120.0K | $10.9K | $3.0K | |
| Pretax Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-17M | $-23M | $-14M | $-10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $164.0K | $0 | $-312.0K | $1M | $162.0K | $203.9K | $-18 | |
| Net Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| EPS (Basic) | $-3.71 | $-7.83 | $2.19 | $-0.45 | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.71 | $-7.83 | $2.17 | · | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| Shares (Basic) | 11,251,250 | 2,225,934 | 1,770,167 | 74,172,000 | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 11,251,250 | 2,225,934 | 1,793,980 | · | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| EBITDA | $-39M | $-14M | · | $-41M | · | $-34M | $-27M | $-31M | $-15M | · | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $84M | $7M | $39M | $118M | $70M | $62M | $75M | $38M | $29M | $29M | $18M | |
| Short-term Investments | $0 | · | $9M | $21M | $0 | $0 | $42M | $53M | $35M | $0 | · | · | |
| Receivables | $0 | $358.0K | $0 | $6M | $3M | $2M | $7M | $3M | $16M | $57.0K | $0 | $0 | |
| Prepaid Expense | $1M | $2M | $198.0K | $3M | $7M | $4M | $4M | $5M | $2M | $3M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $59M | $88M | $8M | $73M | $128M | $76M | $115M | $135M | $90M | $33M | $32M | $20M | |
| PP&E (Net) | · | · | $0 | $17M | $19M | $22M | $20M | $5M | $4M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | · | $27M | $27M | $28M | $23M | $8M | $7M | $5M | $4M | $4M | |
| Accum. Depreciation | · | · | · | $10M | $8M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | $0 | $1M | $3M | $3M | $3M | $910.0K | $130.0K | $126.0K | $126.8K | · | |
| Total Assets | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Accounts Payable | $5M | $5M | $936.0K | $4M | $9M | $2M | $6M | $3M | $2M | $2M | $1M | · | |
| Accrued Liabilities | · | · | · | · | · | $8M | $10M | $9M | $6M | $4M | $2M | $986.6K | |
| Current Liabilities | $11M | $12M | $2M | $37M | $51M | $22M | $27M | $48M | $46M | $8M | $3M | $4M | |
| Capital Leases | $431.0K | $0 | $0 | $12M | $14M | $16M | $15M | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | $6.0K | $0 | $27.0K | $37.0K | $47.0K | $23.9K | $334.0K | |
| Total Liabilities | $32M | $26M | $11M | $68M | $103M | $74M | $90M | $101M | $92M | $10M | $3M | $4M | |
| Common Stock | $12.0K | $11.0K | $0 | $74.0K | $72.0K | $56.0K | $55.0K | $54.0K | $45.0K | $43.0K | $39.8K | $29.3K | |
| Paid-in Capital | $163M | $156M | $2M | $319M | $307M | · | · | · | · | · | $112M | $85M | |
| Retained Earnings | $-135M | $-94M | $-76M | $-290M | $-257M | $-211M | $-174M | $-147M | $-120M | $-103M | $-80M | $-66M | |
| AOCI | $83.0K | $3.0K | $0 | $-254.0K | $829.0K | $-295.0K | $-2M | $-3M | $-5M | $-2M | $-1M | $-843.1K | |
| Stockholders' Equity | $28M | $63M | $-74M | $-94M | $51M | $31M | $51M | $40M | $12M | $25M | $31M | $18M | |
| Liabilities + Equity | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Shares Outstanding | 12,380,933 | 11,012,105 | 1,770,167 | 74,519,103 | 72,222,661 | 56,003,000 | 55,212,437 | 54,151,219 | 45,017,062 | 43,058,827 | 39,833,023 | 29,279,522 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2M | $3M | $2M | · | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $830.0K | $603.0K | $4M | $5M | $5M | $5M | $5M | $3M | $2M | $1M | $571.4K | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $0 | $-164.0K | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | $-34M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-11M | $-14M | $-60M | $-8M | $-46M | $-52M | $-1M | $50M | $-14M | $-13M | $-5M | |
| CapEx | · | · | $171.0K | $1M | $949.0K | $3M | $2M | $2M | $2M | $560.0K | $620.7K | $267.4K | |
| Investing Cash Flow | · | · | $12M | $-21M | $-949.0K | $39M | $10M | $-9M | $-46M | · | · | · | |
| Stock Issued | · | · | $20M | $7M | $38M | $10M | · | · | · | · | $26M | $12M | |
| Net Stock Activity | · | · | · | $7M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-660.0K | $87M | $5M | $7M | $59M | $10M | $32M | $49M | $4M | · | · | · | |
| Net Change in Cash | $-26M | $76M | $-9M | $-79M | $47M | $8M | $-13M | $37M | $9M | $6.0K | $11M | $15M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $51.7K | |
| Free Cash Flow | · | · | · | $-61M | · | $-49M | $-55M | $-3M | $48M | · | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1490.4% | · | · | -167.8% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| Net Margin | -1610.6% | · | · | -128.5% | · | -127.0% | -55.0% | -91.9% | -69.8% | · | · | · | |
| Pretax Margin | -1610.6% | · | · | -128.5% | · | -126.4% | -55.0% | -93.0% | -65.5% | · | · | · | |
| EBITDA Margin | -1490.4% | · | · | -157.1% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| ROA | -56.5% | -36.4% | · | -26.7% | · | -30.3% | -17.9% | -21.8% | -25.4% | · | · | · | |
| ROE | -110.1% | 140.6% | · | -92.1% | · | -99.7% | -70.8% | -59.3% | -96.0% | · | · | · | |
| ROIC | -137.9% | -22.5% | · | -155.7% | · | -109.8% | -52.9% | -76.3% | -135.1% | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 7.3 | · | 2.0 | · | 3.4 | 4.3 | 2.8 | 2.0 | · | · | · | |
| Quick Ratio | 5.1 | 7.0 | · | 1.8 | · | 3.3 | 4.1 | 2.7 | 1.9 | · | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.2 | · | 0.2 | 0.3 | 0.2 | 0.4 | · | · | · | |
| Receivables Turnover | 14.5 | · | · | 5.7 | · | 6.9 | 9.8 | 3.2 | 3.2 | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.26 | $5.69 | · | $0.37 | · | $0.55 | $0.93 | $0.74 | $0.26 | · | · | · | |
| Revenue / Share | $0.23 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.22 | $-4.87 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $4.68 | $7.59 | · | $0.52 | · | $1.26 | $1.13 | $1.38 | $0.84 | · | · | · | |
| EPS (TTM) | $-3.71 | $-7.83 | $2.17 | $-0.70 | $-0.71 | $-0.68 | · | · | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 65.3% | -17.6% | 7.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | 13.4% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| Net Income TTM | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| Market Cap | $1.30B | $132M | · | $6.20B | · | $11.20B | $15.99B | $11.52B | $27.19B | · | · | · | |
| P/E | -28.2 | -1.5 | 6.7 | -118.9 | -425.9 | -294.1 | · | · | · | · | · | · | |
| P/S | 66.2 | 6.8 | · | 239.4 | · | 382.0 | 345.5 | 396.0 | 1075.8 | · | · | · | |
| P/B | 46.3 | 2.1 | · | 222.0 | · | 361.0 | 311.4 | 288.6 | 2359.9 | · | · | · | |
| P / Tangible Book | 46.3 | 2.1 | · | · | 430.3 | 361.0 | · | · | · | · | · | · | |
| P / Cash Flow | -51.8 | -12.2 | · | -103.5 | · | -244.0 | -304.8 | -10809.9 | 546.5 | · | · | · | |
| P / FCF | · | · | · | -101.7 | · | -230.4 | -291.1 | -4169.1 | 568.8 | · | · | · | |
| Earnings Yield | -3.5% | -65.2% | 14.9% | -0.84% | -0.23% | -0.34% | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $0 | $0 | $53.0K | · | $20M | $20M | $2M | $6M | $5M | |
| R&D Expense | $12M | $9M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $984.0K | $-29M | $10M | $14M | $13M | $13M | $14M | |
| SG&A Expense | $9M | $6M | $4M | $4M | $4M | $4M | $2M | $2M | $1M | $775.0K | $-11M | $7M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $21M | $15M | $11M | $10M | $9M | $8M | $4M | $5M | $3M | $2M | $-55M | $31M | $18M | $17M | $17M | $18M | |
| Operating Income | $-21M | $-15M | $-11M | $-10M | $-9M | $-8M | $-4M | $-5M | $-3M | $-2M | $13M | $-12M | $2M | $-16M | $-12M | $-12M | |
| Other Non-op | $-8.0K | $-32.0K | $-92.0K | $34.0K | $561.0K | $224.0K | $-175.0K | $-20.0K | $64.0K | $0 | $424.0K | $506.0K | $-161.0K | $-57.0K | $-325.0K | $723.0K | |
| Pretax Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | $39M | $-11M | $4M | $-13M | $-8M | $-10M | |
| EPS (Basic) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $21.41 | $-8.70 | $3.63 | $-14.15 | $-0.11 | $-0.13 | |
| EPS (Diluted) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $20.50 | $-8.70 | $3.62 | · | · | · | |
| Shares (Basic) | 14,356,219 | 13,085,271 | · | 11,064,282 | 11,052,741 | 11,013,697 | · | 1,770,167 | 1,770,167 | 1,770,167 | · | 1,236,000 | 1,095,000 | 931,000 | · | 74,397,000 | |
| Shares (Diluted) | 14,356,219 | 13,085,271 | · | 11,064,282 | 11,052,741 | 11,013,697 | · | 1,770,167 | 1,770,167 | 1,770,167 | · | 1,236,000 | 1,098,000 | · | · | · | |
| EBITDA | $-21M | $-15M | · | $-10M | $-9M | $-8M | · | $-3M | $-4M | $-5M | · | $-12M | $2M | $-15M | · | $-12M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $188M | $206M | $58M | $64M | $70M | $76M | $84M | $19M | $20M | $19M | $7M | $33M | $45M | $40M | $39M | $48M | |
| Short-term Investments | $63M | $55M | · | · | · | · | · | $0 | $0 | $0 | · | $12M | $10M | $9M | $21M | $21M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $358.0K | $373.0K | $1M | $2M | $0 | $1M | $952.0K | $1M | $6M | $829.0K | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $280.0K | $649.0K | $3M | $198.0K | $9M | $11M | $11M | $3M | $8M | |
| Current Assets | $253M | $263M | $59M | $67M | $74M | $79M | $88M | · | · | · | $8M | $59M | $66M | $61M | $73M | $79M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $0 | $16M | $17M | $17M | $16M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | $27M | $27M | $27M | $24M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | $11M | $10M | $10M | $8M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $287.0K | $1M | $1M | $1M | $1M | |
| Total Assets | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Accounts Payable | $7M | $5M | $5M | $3M | $5M | $4M | $5M | $801.0K | $969.0K | $2M | $936.0K | $3M | $8M | $6M | $4M | $4M | |
| Current Liabilities | $12M | $9M | $11M | $10M | $10M | $9M | $12M | $4M | $6M | $8M | $2M | $29M | $34M | $43M | $37M | $34M | |
| Capital Leases | $318.0K | $375.0K | $431.0K | · | · | · | $0 | · | · | · | · | $0 | $12M | $12M | $12M | $11M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Total Liabilities | $37M | $31M | $32M | $28M | $26M | $24M | $26M | · | · | · | $11M | $29M | $47M | $67M | $68M | $63M | |
| Common Stock | $14.0K | $14.0K | $12.0K | $11.0K | $11.0K | $11.0K | $11.0K | $1.0K | $1.0K | $1.0K | $0 | $99.0K | $99.0K | $74.0K | $74.0K | $74.0K | |
| Paid-in Capital | $390M | $383M | $163M | $161M | $159M | $157M | $156M | $343M | $343M | $342M | $2M | $341M | $340M | $319M | $319M | $317M | |
| Retained Earnings | $-173M | $-151M | $-135M | $-123M | $-111M | $-102M | $-94M | $-326M | $-323M | $-320M | $-76M | $-310M | $-300M | $-304M | $-290M | $-282M | |
| AOCI | $89.0K | $95.0K | $83.0K | $104.0K | $-111.0K | $-3.0K | $3.0K | $-316.0K | $-436.0K | $-346.0K | $0 | $-339.0K | $-137.0K | $-426.0K | $-254.0K | $524.0K | |
| Stockholders' Equity | $217M | $232M | $28M | $39M | $48M | $56M | $63M | $16M | $19M | $22M | $-74M | $31M | $40M | $15M | $28M | $36M | |
| Liabilities + Equity | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Shares Outstanding | 14,395,705 | 14,313,659 | 12,380,933 | 11,088,329 | 11,059,665 | 11,021,389 | 11,012,105 | 1,320,240 | 1,320,240 | 1,236,688 | 1,770,167 | · | 98,851,927 | 74,519,103 | 74,519,103 | 74,406,253 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $0 | $0 | $-30.0K | · | $739.0K | $758.0K | $605.0K | $575.0K | $767.0K | |
| Stock-based Comp | $5M | $3M | $2M | $2M | $1M | $1M | $268.0K | $-331.0K | $-109.0K | $146.0K | $-2M | $966.0K | $1M | $884.0K | $949.0K | $974.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-13M | $-11M | $-5M | $-8M | $-5M | $-7M | $-5M | $3M | $4M | $-1M | $20M | $-10M | $-13M | $-11M | $-13M | $-9M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $69.0K | $67.0K | $48.0K | $-11.0K | $34.0K | |
| Investing Cash Flow | $-7M | $-55M | · | · | $0 | $0 | · | $142.0K | $2M | $9M | · | $-2M | $-1M | $12M | $1M | $5M | |
| Stock Issued | $0 | $230M | · | · | $0 | $0 | · | $0 | · | · | · | $0 | $20M | $0 | $0 | $282.0K | |
| Net Stock Activity | · | $230M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $1M | $215M | $-49.0K | $242.0K | $349.0K | $-1M | $75M | $12M | $10M | $0 | $-15M | $0 | $20M | $0 | $93.0K | $282.0K | |
| Net Change in Cash | $-19M | $148M | $-6M | $-7M | $-5M | $-8M | $69M | $5M | $5M | $-1M | $-3M | $-12M | $5M | $1M | $-10M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $-11M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10005.7% | · | -60.5% | 10.3% | -801.2% | · | -226.6% | |
| Net Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | -9230.2% | · | -55.1% | 19.8% | -680.9% | · | -181.3% | |
| Pretax Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10062.3% | · | -60.5% | 10.3% | -769.9% | · | -226.6% | |
| ROA | -13.4% | -9.2% | · | -25.9% | -19.2% | -15.0% | · | -7.2% | -6.4% | -8.8% | · | -13.6% | 3.9% | -12.0% | · | -7.4% | |
| ROE | -16.5% | -10.9% | · | -41.3% | -28.5% | -21.1% | · | -12.3% | -12.1% | -26.2% | · | -32.5% | 9.4% | -38.3% | · | -21.7% | |
| ROIC | -9.9% | -6.4% | · | -26.3% | -19.4% | -14.2% | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.2 | 28.9 | · | 6.5 | 7.7 | 8.8 | · | · | · | · | · | 2.0 | 1.9 | 1.4 | · | 2.3 | |
| Quick Ratio | 21.0 | 28.7 | · | 6.2 | 7.3 | 8.4 | · | 4.6 | 3.3 | 2.8 | · | 1.6 | 1.6 | 1.2 | · | 2.1 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.2 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 3.4 | 0.9 | 0.8 | · | 0.0 | 0.0 | 0.0 | · | 20.8 | 18.1 | 1.4 | · | 1.4 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.06 | $16.23 | · | $3.49 | $4.32 | $5.04 | · | $12.32 | $14.17 | $17.76 | · | · | $0.41 | $0.21 | · | $0.48 | |
| Revenue / Share | $0.14 | $0.08 | · | $0.06 | $0.06 | $0.07 | · | $0.00 | $0.00 | · | · | · | $0.23 | · | · | · | |
| Cash Flow / Share | · | $-0.83 | · | · | · | $-0.61 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $13.05 | $14.42 | · | $5.73 | $6.37 | $6.86 | · | $14.67 | $14.95 | $15.43 | · | · | $0.45 | $0.53 | · | $0.65 | |
| EPS (TTM) | $-4.83 | $-4.17 | · | $-2.51 | $-5.42 | $-7.03 | · | $12.55 | $7.79 | $13.88 | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $47M | $33M | $17M | · | $28M | |
| Net Income TTM | $-62M | $-49M | · | $-33M | $-28M | $-23M | · | $25M | $21M | $29M | · | $-28M | $-27M | $-41M | · | $-35M | |
| Market Cap | $2.20B | $1.78B | · | $695M | $249M | $308M | · | $22M | $13M | $18M | · | · | $1.31B | $5.82B | · | $6.85B | |
| P/E | -31.6 | -29.9 | · | -25.0 | -4.2 | -4.0 | · | 1.3 | 1.3 | 1.1 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | 39.5 | 345.3 | · | 240.2 | |
| P/B | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Tangible Book | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Cash Flow | · | -164.2 | · | · | · | -45.6 | · | · | · | -2.6 | · | · | · | -529.1 | · | · | |
| Earnings Yield | -3.2% | -3.4% | · | -4.0% | -24.1% | -25.1% | · | 75.7% | 79.4% | 94.8% | · | · | · | · | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | · | · | $43M | $26M | $31M |
| Margine Operativo % | -1490.4% | · | · | -167.8% | · |
| Utile netto | $-42M | $-17M | $19M | $-33M | $-46M |
| EPS Diluito | $-3.71 | $-7.83 | $2.17 | · | $-0.71 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 5.2 | 7.3 | · | 2.0 | · |
| Quick Ratio | 5.1 | 7.0 | · | 1.8 | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | · | · | $-61M | · |
Proprietari istituzionali (13F) 210 filer · $2.2B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
210
Valore detenuto
$2.2B
Nuove posizioni
35
Posizioni chiuse
19
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 35 (-35 vs trimestre precedente) | 19 (-3 vs trimestre precedente) | 93 (+24 vs trimestre precedente) | 45 (+15 vs trimestre precedente) | +820K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $173.512.745 | 1.135.406 | 7,97% | Azioni |
| JENNISON ASSOCIATES LLC | $146.801.795 | 960.619 | 6,75% | Azioni |
| BlackRock, Inc. | $140.343.317 | 918.357 | 6,45% | Azioni |
| Frazier Life Sciences Management, L.P. | $134.848.368 | 882.400 | 6,20% | Azioni |
| First Light Asset Management, LLC | $117.961.911 | 771.901 | 5,42% | Azioni |
| BVF INC/IL | $102.815.615 | 672.789 | 4,72% | Azioni |
| STATE STREET CORP | $99.817.745 | 653.172 | 4,59% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $78.517.999 | 513.794 | 3,61% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $73.175.272 | 478.833 | 3,36% | Azioni |
| FEDERATED HERMES, INC. | $66.173.352 | 433.015 | 3,04% | Azioni |
| VANGUARD GROUP INC | $58.679.676 | 560.616 | 2,70% | Azioni |
| Woodline Partners LP | $48.522.948 | 317.517 | 2,23% | Azioni |
| ORBIMED ADVISORS LLC | $44.678.455 | 292.360 | 2,05% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $42.213.033 | 276.164 | 1,94% | Azioni |
| Siren, L.L.C. | $39.348.858 | 257.485 | 1,81% | Azioni |
| PRIMECAP MANAGEMENT CO/CA/ | $39.149.734 | 256.182 | 1,80% | Azioni |
| EVENTIDE ASSET MANAGEMENT, LLC | $35.375.385 | 231.484 | 1,63% | Azioni |
| EMERALD ADVISERS, LLC | $35.070.051 | 229.486 | 1,61% | Azioni |
| FMR LLC | $32.831.927 | 214.841 | 1,51% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $31.557.391 | 253.168 | 1,45% | Azioni |
| MPM BIOIMPACT LLC | $31.179.406 | 204.027 | 1,43% | Azioni |
| GOLDMAN SACHS GROUP INC | $30.795.370 | 201.514 | 1,42% | Azioni |
| MORGAN STANLEY | $27.725.827 | 181.428 | 1,27% | Azioni |
| First Turn Management, LLC | $23.908.689 | 156.450 | 1,10% | Azioni |
| Bellevue Group AG | $23.687.100 | 155.000 | 1,09% | Azioni |
| Caption Management, LLC | $21.394.800 | 140.000 | 0,98% | Opzione Put |
| EMERALD MUTUAL FUND ADVISERS TRUST | $19.843.219 | 129.847 | 0,91% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.707.973 | 128.962 | 0,91% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.430.092 | 120.600 | 0,85% | Opzione Call |
| Aberdeen Group plc | $18.374.771 | 120.238 | 0,84% | Azioni |
| NORTHERN TRUST CORP | $14.853.034 | 97.193 | 0,68% | Azioni |
| NEXTBio Capital Management LP | $13.739.893 | 89.909 | 0,63% | Azioni |
| Clio Asset Management LLC | $13.194.937 | 86.343 | 0,61% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $12.700.411 | 83.107 | 0,58% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.706.012 | 76.600 | 0,54% | Opzione Put |
| VANGUARD FIDUCIARY TRUST CO | $11.307.916 | 73.995 | 0,52% | Azioni |
| UBS Group AG | $11.083.424 | 72.526 | 0,51% | Azioni |
| Avidity Partners Management LP | $10.697.400 | 70.000 | 0,49% | Azioni |
| AWM Investment Company, Inc. | $10.608.153 | 69.416 | 0,49% | Azioni |
| SEVEN GRAND MANAGERS, LLC | $9.169.200 | 60.000 | 0,42% | Azioni |
| Clearbridge Investments, LLC | $9.068.458 | 59.341 | 0,42% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $8.713.159 | 69.901 | 0,40% | Azioni |
| BANK OF AMERICA CORP /DE/ | $8.336.942 | 54.554 | 0,38% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $8.140.721 | 53.270 | 0,37% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $7.979.038 | 52.212 | 0,37% | Azioni |
| Ensign Peak Advisors, Inc | $7.894.681 | 51.660 | 0,36% | Azioni |
| HSBC HOLDINGS PLC | $7.641.156 | 50.001 | 0,35% | Azioni |
| Nicholas Investment Partners, LP | $7.597.905 | 49.718 | 0,35% | Azioni |
| Balyasny Asset Management L.P. | $6.805.992 | 44.536 | 0,31% | Azioni |
| Lisanti Capital Growth, LLC | $6.567.440 | 42.975 | 0,30% | Azioni |
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Kaupinen Wes, Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Christine L. Kaupinen, Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Michael Christopher | 20 Dicembre 2024 | 14,60% | Deposito iniziale | · | SEC |
| Biotechnology Value Fund, L.P., BVF I GP LLC, Biotechnology Value Fund II, L.P., BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP Holdings LLC, BVF Partners L.P., BVF Inc., Mark N. Lampert ×2 depositi | 17 Agosto 2023 | · | Deposito iniziale | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP III LLC ×10 depositi | 27 Settembre 2018 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 34 insider · 16 dirigenti · 19 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kaupinen Wes | President and CEO | 05 Febbraio 2026 A | · | 0 | 0 | $0 |
| Stephen S. Yoder | Chief Executive Officer | 24 Febbraio 2023 A | 6.000 | 0 | 0 | $0 |
| Matthew E Korenberg | CFO, Treasurer | 12 Giugno 2026 M | 1.000 | 0 | 0 | $0 |
| Thomas Bures | Chief Financial Officer | 24 Febbraio 2023 A | · | 0 | 0 | $0 |
| Allan Reine | Chief Financial Officer | 26 Febbraio 2019 A | 65.000 | 0 | 0 | $0 |
| Darlene M Deptula-Hicks | SVP, Chief Financial Officer | 13 Giugno 2016 P | 5.000 | 0 | 0 | $0 |
| Kathleen Goin | Chief Operating Officer | 16 Settembre 2026 M | 0 | 0 | 33 | $-5.506.479 |
| Ashley Hartmann Kline | Chief Commercial Officer | 05 Febbraio 2026 A | · | 0 | 0 | $0 |
| Jeffrey S Martini | Chief Scientific Officer | 05 Febbraio 2026 A | · | 0 | 0 | $0 |
| PALVELLA THERAPEUTICS, INC. | Chief Scientific Officer | 05 Febbraio 2025 A | · | 0 | 0 | $0 |
| Ahmed Mousa | Chief Business Officer | 24 Febbraio 2023 A | · | 0 | 0 | $0 |
| Shane Olwill | Chief Development Officer | 24 Febbraio 2023 A | 4.638 | 0 | 0 | $0 |
| Hitto Kaufmann | Chief Scientific Officer | 24 Febbraio 2023 A | · | 0 | 0 | $0 |
| Tim Demuth | Chief Medical Officer | 13 Maggio 2022 P | 6.000 | 0 | 0 | $0 |
| Louis Matis | Chief Development Officer | 26 Febbraio 2019 A | 10.000 | 0 | 0 | $0 |
| Claude Knopf | Chief Business Officer | 28 Novembre 2016 A | · | 0 | 0 | $0 |
| George M Jenkins | Direttore | 15 Settembre 2026 S | 160.116 | 2 | 9 | $-3.617.215 |
| Christopher P Kiritsy | Direttore | 02 Settembre 2026 M | 250 | 0 | 1 | $-49.141 |
| Matthew Pauls | Direttore | 29 Giugno 2026 A | · | 0 | 0 | $0 |
| Tadd S. Wessel | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| John Doux | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Todd C Davis | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Elaine J Heron | Direttore | 10 Giugno 2026 A | 47.812 | 1 | 0 | $300.000 |
| James A Geraghty | Direttore | 12 Dicembre 2024 D | 0 | 0 | 0 | $0 |
| Maya R. Said | Direttore | 21 Giugno 2023 A | · | 0 | 0 | $0 |
| Ann Barbier | Direttore | 21 Giugno 2023 A | · | 0 | 0 | $0 |
| Michael Richman | Direttore | 21 Giugno 2023 A | · | 0 | 0 | $0 |
| Peter A Kiener | Direttore | 21 Giugno 2023 A | · | 0 | 0 | $0 |
| Matthew L Sherman | Direttore | 21 Giugno 2023 A | · | 0 | 0 | $0 |
| Jean-Pierre Bizzari | Direttore | 25 Gennaio 2020 A | · | 0 | 0 | $0 |
| Steven Prelack | Direttore | 25 Gennaio 2019 A | · | 0 | 0 | $0 |
| Julian Adams | Direttore | 25 Gennaio 2018 A | · | 0 | 0 | $0 |
| Chau Quang Khuong | Direttore | 25 Ottobre 2017 A | 65.398 | 0 | 0 | $0 |
| Aquilo Capital Management, LLC | Proprietario del 10% | 21 Luglio 2020 S | 3.675.530 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 23 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,13% | 24.487 SH | 02 Ottobre 2026 | Giornaliero |
| BBC · ETFis Series Trust I | 0,86% | 2.856 NS | 31 Luglio 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,74% | 22.508 SH | 02 Ottobre 2026 | Giornaliero |
| LABU · Direxion Shares ETF Trust | 0,39% | 13.887 NS | 31 Luglio 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,18% | 22.955 SH | 19 Agosto 2026 | Giornaliero |
| PWS · Pacer Funds Trust | 0,11% | 190 NS | 31 Luglio 2026 | N-PORT |
| IWO · iShares Trust | 0,11% | 103.168 SH | 11 Settembre 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 11.762 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,05% | 280.820 SH | 11 Settembre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 63.184 SH | 19 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,05% | 5.240 NS | 31 Luglio 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 1.583 SH | 11 Settembre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 4.864 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 113.556 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,02% | 30.157 SH | 19 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,02% | 674 SH | 10 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 3.420 SH | 03 Settembre 2026 | Giornaliero |
| ITOT · iShares Trust | 0,00% | 14.740 SH | 11 Settembre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,00% | 218 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 388.390 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 904 SH | 19 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | · | 450 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 1.075 SH | 11 Settembre 2026 | Giornaliero |
PVLA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 22 analisti
COMPRA
Target mediano
$232.00
+75,1%
6 27,3%
Acquisto forte
15 68,2%
Compra
1 4,5%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
15 analisti · 2026-09-28Target medio $230.53 +74,0%
← Sotto tutti i target
Prezzo attuale $132.47
Basso$205.00
Media$230.53
Alto$270.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | · |
| GENB | · | · | · | · | · | · |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | · |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | · |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 4, 2026